CANCER TREATMENT PROGRAM AREA

Program Coordinators: Stephen K. Carter, United States
Yoshio Sakurai, Japan
Principal Advisors: Hirokoi Koyama, Japan (Breast Cancer)
Tadao Niijima, Japan (Bladder Cancer)
Shoji Hattori, Japan (Lung Cancer)
Franco Muggia, United States (Chemotherapy)
Steven Rosenberg, United States (Immunotherapy)
Yuichi Yamamura, Japan (Immunotherapy)
Glenn Sheline, United States (Radiation Oncology)
Yoichiro Umegaki, Japan (Radiation Oncology)

ADMINISTRATIVE REPORT

SEMINARS AND MEETINGS

Sixth Annual Program Review meeting of the Cancer Treatment Program Area of the U.S.-Japan Cooperative Cancer Research Program
Location: Tokyo, Japan
Dates: June 7 and 8, 1980

Seminar on "High LET Radiation and Combined Modalities"
Location: Honolulu, Hawaii
Dates: November 10 to November 12, 1980
Organizers: Glenn Sheline and Yoichiro Umegaki


EXCHANGE OF SCIENTISTS

Dr. Lynn James Verhey, Massachusetts General Hospital, Boston, Massachusetts
Dates: April 16 to April 25, 1980
Host Scientist: Dr. Yoichiro Umegaki, National Institute of Radiological Sciences (NIRS), Chiba
Subject: Study of dosimetric intercomparisons in both cobalt-60 treatment beams and proton beams.

George T. Bryan, M.D., University of Wisconsin, Madison, Wisconsin
Dates: July 17 to August 16, 1980
Host Scientists: Various sponsors at several centers
Subject: Study of Japanese bladder cancer research; review and stimulation of U.S.-Japan collaborative research on bladder cancer.

Takeshi Horai M.D., The Center for Adult Diseases, Osaka
Dates: February 9 to March 30, 1981
Host Scientist: Dr. Myron R. Melamed, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York
Dr. Clifton F. Mountain, Thoracic Oncology, M.D. Anderson Hospital and Tumor Institute, Houston, Texas
Dr. John D. Minna, NCI-VA Medical Branch, Veterans Administration Hospital, Washington, D.C.
Subject: Intensive chemotherapy of lung cancer in the United States.
Subtypes of small cell carcinoma, and the relation between prognosis of patients and cytologic findings.
Cell kinetics and its application to the treatment of lung cancer.




EXCHANGE OF MATERIALS

A continued exchange of drugs for preclinical study has occurred during the past year. The data on screening, as well as some number of compounds themselves, were put into the screening program of the United States' National Cancer Institute.

Meeting on "Chemo-endocrine Therapy of Breast Cancer"
Location: San Antonio, Texas
Dates: March 2 to March 4, 1981
Organizers: William McGuire and Hiroki Koyama